Trytosaveabit commented on a stock · Jan 30 07:37

Update

$NeuroSense Therapeutics(NRSN.US)$ NeuroSense's (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
ACCESSWIRE 30-Jan-2024 8:32 AM

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2778 Views

Comment

Trytosaveabit

1796Followers

29Following

21KVisitors